Gene · 8564
Papers1,472
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,472
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19. | Front Immunol | 2022 | 35844544 | PubTator, text mining | PubMed |
| The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis. | BMC Infect Dis | 2022 | 35840908 | PubTator, text mining | PubMed |
| Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders. | Front Psychiatry | 2022 | 35836656 | PubTator, text mining | PubMed |
| Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle? | Cell Mol Life Sci | 2022 | 35821534 | PubTator, text mining | PubMed |
| Altered Regulation of mRNA and miRNA Expression in Epithelial and Stromal Tissue of Keratoconus Corneas. | Invest Ophthalmol Vis Sci | 2022 | 35816043 | PubTator, text mining | PubMed |
| Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma. | Front Immunol | 2022 | 35812404 | PubTator, text mining | PubMed |
| Identification of Genetic Variations in the NAD-Related Pathways for Patients with Major Depressive Disorder: A Case-Control Study in Taiwan. | J Clin Med | 2022 | 35806906 | PubTator, text mining | PubMed |
| Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications. | J Cardiovasc Aging | 2022 | 35801078 | PubTator, text mining | PubMed |
| The Footprint of Kynurenine Pathway in Cardiovascular Diseases. | Int J Tryptophan Res | 2022 | 35784899 | PubTator, text mining | PubMed |
| Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Monocyte-to-Lymphocyte Ratio in Depression: An Updated Systematic Review and Meta-Analysis. | Front Psychiatry | 2022 | 35782448 | PubTator, text mining | PubMed |
| Prevalence and Predictors of Toxoplasma gondii Infection in Psychiatric Inpatients in Fars Province, Southern Iran. | Front Psychiatry | 2022 | 35774089 | PubTator, text mining | PubMed |
Kynurenine monooxygenase inhibition and associated reduced quinolinic acid reverses depression-like behaviour by upregulating Nrf2/ARE pathway in mouse model of depression: In-vivo and In-silico studies. | Neuropharmacology | 2022 | 35753430 | PubTator, text mining | PubMed |
| The Construction Strategy of a New Model of College Students' Psychological Education under the Network Environment. | J Environ Public Health | 2022 | 35747518 | PubTator, text mining | PubMed |
| The Kynurenine Pathway in Obese Middle-Aged Women with Normoglycemia and Type 2 Diabetes. | Metabolites | 2022 | 35736425 | PubTator, text mining | PubMed |
| Analgesic Activity of Cinnabarinic Acid in Models of Inflammatory and Neuropathic Pain. | Front Mol Neurosci | 2022 | 35721314 | PubTator, text mining | PubMed |
| Further characterization of tryptophan metabolism and its dysregulation in fibroids. | F S Sci | 2022 | 35715314 | PubTator, text mining | PubMed |
| Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19. | Sci Rep | 2022 | 35705608 | PubTator, text mining | PubMed |
| Development and Validation of Structured COVID Perception Interview Guide (COPING) for Assessing the Acute Impact of COVID-19 Diagnosis. | J Neurosci Rural Pract | 2022 | 35694061 | PubTator, text mining | PubMed |
| An Emerging Cross-Species Marker for Organismal Health: Tryptophan-Kynurenine Pathway. | Int J Mol Sci | 2022 | 35682980 | PubTator, text mining | PubMed |
| Analysis of the Mediating Role of Psychological Empowerment between Perceived Leader Trust and Employee Work Performance. | Int J Environ Res Public Health | 2022 | 35682296 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8564/papers?page=21